110 related articles for article (PubMed ID: 24258315)
1. Optimizing biologically targeted clinical trials for neurofibromatosis.
Gutmann DH; Blakeley JO; Korf BR; Packer RJ
Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C
Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489
[TBL] [Abstract][Full Text] [Related]
3. Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.
Wang KE; Vranceanu AM; Lester EG
PLoS One; 2023; 18(12):e0295546. PubMed ID: 38127915
[TBL] [Abstract][Full Text] [Related]
4. Living with neurofibromatosis.
Murphy L; Andrawis M; Beatty P; Costa Blasco M; Doyle C; McFeely O; O'Mahony S; Wolinska A; Connolly M
Clin Exp Dermatol; 2023 Sep; 48(10):1192-1193. PubMed ID: 37403671
[No Abstract] [Full Text] [Related]
5. Neurofibromatosis: emerging phenotypes, mechanisms and management.
Huson S
Clin Med (Lond); 2008 Dec; 8(6):611-7. PubMed ID: 19149284
[No Abstract] [Full Text] [Related]
6. Whole-body MR imaging for improved detection of neurofibromatosis: an integrated technical note to estimate true extent.
Theodorou DJ; Theodorou SJ; Petsanas AP
Neurosurg Rev; 2023 Sep; 46(1):236. PubMed ID: 37682365
[No Abstract] [Full Text] [Related]
7. Neurofibromatosis type 1: a multidisciplinary approach to care.
Hirbe AC; Gutmann DH
Lancet Neurol; 2014 Aug; 13(8):834-43. PubMed ID: 25030515
[TBL] [Abstract][Full Text] [Related]
8. Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.
Kotch C; Wagner K; Broad JH; Dombi E; Minturn JE; Phillips P; Smith K; Li Y; Jacobs IN; Elden LM; Fisher MJ; Belasco J
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174087
[TBL] [Abstract][Full Text] [Related]
9. Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.
Jiang C; Kumar A; Yu Z; Shipman T; Wang Y; McKay RM; Xing C; Le LQ
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140985
[TBL] [Abstract][Full Text] [Related]
10. Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019.
Collins-Sawaragi YC; Ferner R; Vassallo G; De Agrò G; Eccles S; Cadwgan J; Hargrave D; Hupton E; Eelloo J; Lunt L; Tang V; Burkitt Wright E; Lascelles K
Am J Med Genet A; 2022 Jun; 188(6):1723-1727. PubMed ID: 35178860
[TBL] [Abstract][Full Text] [Related]
11. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.
Isakson SH; Rizzardi AE; Coutts AW; Carlson DF; Kirstein MN; Fisher J; Vitte J; Williams KB; Pluhar GE; Dahiya S; Widemann BC; Dombi E; Rizvi T; Ratner N; Messiaen L; Stemmer-Rachamimov AO; Fahrenkrug SC; Gutmann DH; Giovannini M; Moertel CL; Largaespada DA; Watson AL
Commun Biol; 2018; 1():158. PubMed ID: 30302402
[TBL] [Abstract][Full Text] [Related]
13. [CNS manifestations of neurocutaneous syndromes].
Yilmaz U
Radiologe; 2018 Jul; 58(7):664-667. PubMed ID: 29947935
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatoses].
Zimmer A
Radiologe; 2013 Dec; 53(12):1077-83. PubMed ID: 24258315
[TBL] [Abstract][Full Text] [Related]
15. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
Ferner RE
Lancet Neurol; 2007 Apr; 6(4):340-51. PubMed ID: 17362838
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis: types 1 and 2.
Borofsky S; Levy LM
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2250-1. PubMed ID: 23598837
[TBL] [Abstract][Full Text] [Related]
18. Pediatric schwannomatosis, a rare but distinct form of neurofibromatosis.
Thomas AK; Egelhoff JC; Curran JG; Thomas B
Pediatr Radiol; 2016 Mar; 46(3):430-5. PubMed ID: 26546566
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmological issues in the neurofibromatoses.
Korf BR
J Pediatr Ophthalmol Strabismus; 1996; 33(4):255-9. PubMed ID: 8827563
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
